Lets Go是Reso Health的人工智能旗舰健康平台，旨在为雇主、保险公司和医疗机构提供全面、以数字 驱动的健康管理解决方案。Lets Go以拥有400年历史的中国传统中医品牌"叶开泰"的预防医疗理念为基 础，结合传统医学智慧与现代人工智能技术，在全球大健康领域提供解决方案。 格隆汇11月21日丨北大资源(00618.HK)公告，公司欣然宣布成立人工智能医疗谘询服务委员会，旨在为 公司董事会("董事会"提供战略指导和专家见解，协助推动集团的人工智能驱动的数字健康平台Lets Go 的发展，该平台隶属于集团全资子公司香港富合控股有限公司及创新部门Resohealth FZCO。成立谘询 委员会反映集团致力于在包括阿联酋、东非、印度和东南亚在内的主要新兴市场建设预防医疗生态系统 的承诺。 ...

近日，商汤医疗完成数亿元新一轮战略融资，本轮投资方包括联想创投、联创资本、九弦资本、申冉投 资等多家知名投资机构。这一融资进展印证了市场对商汤医疗领先技术实力、成熟商业模式及价值增长 潜力的高度认可。 今年年初，商汤医疗已获得美的系盈峰控股、人民卫生出版社集团旗下人卫科技发展公司等机构的上亿 元投资。产业方的联合赋能，正推动商汤医疗AI技术在真实医疗场景中加速融合迭代，成功搭建起从 技术研发到产业落地的关键桥梁。目前，商汤医疗已同步启动A轮融资，认购金额超5亿，投后估值超 30亿，融资规模与品牌影响力稳步攀升。 ...

本轮融资认购金额已超5亿元。 文｜海若镜 封面来源｜企业官方 36氪独家获悉，"商汤医疗"近日完成数亿元Pre-A+轮战略融资，投资方包括联想创投、联创资本、九弦 资本、申冉投资等。今年年初，商汤医疗已获得美的系盈峰控股、人民卫生出版社集团旗下人卫科发等 产业资本的上亿元投资。 据商汤医疗介绍，当前公司已启动A轮融资，投后估值超30亿元，本轮融资认购金额已超5亿元。 商汤医疗正依托AI技术，以"通专融合"为技术路径，推动"未来智慧医院"建设，其核心技术引擎包括： 医疗健康大语言模型"大医"、多模态医学图像基础模型群。 这种平台化战略，也符合医院方的隐性需求。很多医院希望供应商能提供有延展性的产品，而不是装十 几款软件、对应十几家厂商。澳门镜湖医院便是一个案例，该院多年来接连采购了商汤医疗十余款人工 智能产品。 为了避免陷入"软件标品"的价格战，商汤医疗搭建了智能体开发、模型应用生产双中台体系，形成"自 主可控+灵活调配"的差异化优势。医院不仅能调用底层大模型能力；还可结合自身优势，利用双中 台，生产特定领域专属模型及智能体，实现智慧医院的升级。 据介绍，商汤集团实行"1+X"战略后，商汤医疗实行独立市场化运营 ...

Core Viewpoint - Southbound funds increased their holdings in iFlytek Medical Technology (02506.HK) by 650.0 shares on November 17, 2025, while experiencing a net reduction of 4,500.0 shares over the past five trading days [1][2]. Group 1: Southbound Fund Activity - In the last 20 trading days, iFlytek Medical Technology saw 12 days of net increases in southbound fund holdings, totaling 82,600 shares [1]. - As of November 17, 2025, southbound funds hold 3.7932 million shares of iFlytek Medical Technology, representing 4.9% of the company's total issued ordinary shares [1][2]. Group 2: Company Overview - iFlytek Medical Technology is primarily engaged in providing AI-powered medical solutions in China, with business lines including grassroots medical services, hospital services, patient services, and regional management platform solutions [2]. - The grassroots medical services line consists of intelligent medical assistants and chronic disease management, while the hospital services line includes smart hospital solutions and diagnostic assistance [2]. - Patient services encompass smart hospital patient services, post-discharge management, imaging cloud platforms, and medical devices [2].

商汤医疗是一家专注于人工智能技术在医疗领域应用的公司。该公司早在2018年世界人工智能大会上正 式发布了首款医疗AI产品原型SenseCare智慧诊疗平台。这一平台能够辅助医生进行诊断、制定治疗规 划及康复建议，支持对多种器官的异常检测、识别及自动诊断分析，主要服务于放射科、病理科、放疗 科、外科及骨科等重点临床科室。SenseCare提供全面的诊断服务，产品支持涵盖13个身体部位及器官 的诊断，包括心脏、肝脏、肺、胃、肠及宫颈等。此外，还为医疗专业人员及患者提供三维手术规划及 康复建议。该平台可以部署在本地或云端，采用专有的高并发渲染技术，支持来自不同医疗机构多个终 端的并发访问。 证券之星消息，根据天眼查APP于11月16日公布的信息整理，上海商汤善萃医疗科技有限公司Pre-A+轮 融资，融资额数亿人民币，参与投资的机构包括联想创投，联创资本，九弦资本，上海申冉，凯乘资 本。 | 公布日 | 投资方 | 交易金额 | 融资轮次 | | --- | --- | --- | --- | | 2025-11-16 | 联想创投 联创 各本 九弦资本 | 数亿人民币 | Pre-A+轮 | | | 世世史史 | ...

一系列融资进展，为商汤医疗蓄力加码，资金将用于医疗大模型的持续迭代、核心产品矩阵的拓展升级以及重点区域市场的布局深化。 为庆贺本轮融资圆满礼成及A轮融资正式开启，商汤医疗将于11月28日举办"智启新生，医领未来——商汤医疗新征程启航盛典"。本次盛典采用定向邀请 制，将通过战略合作签约、未来蓝图发布、高管团队集体亮相等重要环节，全面展现商汤医疗新阶段的战略布局与发展愿景。 近日，商汤医疗完成数亿元新一轮战略融资，本轮投资方包括联想创投、联创资本、九弦资本、申冉投资等多家知名投资机构。这一融资进展印证了市场 对商汤医疗领先技术实力、成熟商业模式及价值增长潜力的高度认可。 今年年初，商汤医疗已获得美的系盈峰控股、人民卫生出版社集团旗下人卫科技发展公司等机构的上亿元投资。产业方的联合赋能，正推动商汤医疗AI 技术在真实医疗场景中加速融合迭代，成功搭建起从技术研发到产业落地的关键桥梁。目前，商汤医疗已同步启动A轮融资，融资规模与市场影响力稳步 攀升。 ...

Group 1 - The 2025 World Internet Conference in Wuzhen highlights the importance of AI in healthcare, showcasing the integration of digital technologies in medical services [4][6] - The theme of the conference is "Building an Open, Cooperative, and Secure Digital Future," celebrating the 10th anniversary of the concept of a community with a shared future in cyberspace [3] - The conference features the "Internet Light" Expo, focusing on AI's contributions to various sectors, including healthcare [7] Group 2 - Qingsong Health Group, established in 2014, focuses on providing comprehensive digital health services and health insurance solutions through an "AI + Health" model [4][6] - The company has developed the "Dr. GPT" model, which enhances medical professionals' diagnostic capabilities and offers personalized health management solutions [6][9] - The "Qingsong AI Assisted Diagnosis Solution" utilizes deep learning for medical imaging analysis, improving diagnostic accuracy and treatment decision-making [7][11] Group 3 - The "Intelligent Inquiry System" within the AI solution provides preliminary diagnostic suggestions based on user symptoms and medical history [9] - The "Chronic Disease Management Plan" offers comprehensive health management for chronic patients, including monitoring and lifestyle adjustment recommendations [9][11] - Qingsong Health Group aims to contribute to global digital health development and support the "Healthy China" strategy through its integrated health ecosystem [11]

Core Insights - The integration of artificial intelligence (AI) in healthcare is transforming medical practices, making advanced technologies like surgical robots and AI-assisted diagnostics a reality [2][3][5] Group 1: AI in Surgical Procedures - AI is enhancing surgical precision, with robots now capable of performing complex procedures that previously required multiple doctors, thus shifting from open surgeries to minimally invasive techniques [3] - The development of intelligent microsurgical robots allows for precise operations in ophthalmology, surpassing human limitations in stability and accuracy [5] Group 2: AI in Medical Research - The concept of creating digital models of entire biological systems for virtual clinical trials is becoming feasible, driven by the integration of vast datasets and advanced AI algorithms [6] - Challenges remain in standardizing medical data and ensuring quality control, which are critical for maximizing the value of healthcare data [6] Group 3: AI in Healthcare Services - AI is positioned as a "super assistant" to doctors, enhancing accessibility to quality healthcare services, particularly in chronic disease management [8] - Innovative applications of AI, such as real-time dietary feedback for diabetes management, demonstrate significant improvements in patient compliance and cost-effectiveness [8] Group 4: Future of AI in Healthcare - The ongoing development of humanoid robots for elderly care and automated pharmacy services indicates a growing trend towards automation in healthcare settings [11] - The "Healthy China 2030" initiative aims to position China as a leader in health technology innovation, promoting a more equitable and intelligent healthcare system [11]

Core Insights - "Zijing Zhikang" has completed nearly 100 million yuan in angel round financing, led by Xinglian Capital, with the funds primarily allocated for the development, iteration, and upgrade of the Zijing AI Hospital system [1] Company Overview - Established in September 2024, Zijing Zhikang was incubated by Tsinghua University's Intelligent Industry Research Institute and initiated by Professor Liu Yang [1] - The company aims to leverage cutting-edge large model AI technology to develop a medical virtual world system and promote its application and optimization in the real world, thereby empowering smart healthcare [1] Technology and Innovation - The core logic of the Zijing AI Hospital is to simulate real hospital facilities and processes, particularly by creating highly human-like, widely distributed, and diverse AI patients to meet initial training data needs [1] - The AI hospital has constructed over 500,000 AI patients covering various countries, age groups, and disease types, serving as an important supplement for training AI doctor agents [2] AI Doctor Development - The team has designed specific memory and reflection algorithms that allow AI doctors to accumulate "experience" during the consultation loop, with validated experiences entering the AI doctor's database as "exclusive memory" [3] - The AI doctors have achieved an accuracy rate exceeding 96% on the MedQA dataset, surpassing the average level of human doctors [3] Product Design and Functionality - The Zijing AI system features three ports: a patient app, a doctor workstation, and a hospital system, facilitating full-cycle health management from pre-diagnosis to post-diagnosis [3] - Patients can register online, engage in intelligent pre-consultation, and generate structured medical records, while doctors can access these records to save time and focus on critical medical decisions [3] Future Plans - The Zijing AI Hospital system is set to launch on June 30, 2025, with internal testing already underway in various departments at Tsinghua University Hospital [4] - Public testing is planned for the end of 2025, expanding from Beijing to more cities and covering various hospital levels and departments [4] Investor Perspectives - Investors highlight the innovative breakthroughs in technology and the potential for Zijing AI Hospital to reshape healthcare efficiency and accessibility [5][6] - The project is seen as a significant force in promoting smart healthcare infrastructure transformation, supported by national policies favoring AI in healthcare [6]

Core Insights - The World Internet Conference in Wuzhen focuses on "Artificial Intelligence," showcasing innovations in the medical field, including the AnDun Life Warning Watch, which addresses healthcare challenges [1][7] - AnDun's Life Warning Watch utilizes the proprietary "Tianhui AI Pulse Diagnosis Algorithm" to provide risk warnings for major diseases and monitor multiple organ functions, creating a personalized health assessment system [2][5] - The fifth generation of AnDun's product line, the X5, is set to launch in Q1 of next year, featuring significant upgrades in core algorithms and user experience to enhance proactive health management [5] - AnDun's founder emphasizes the transformative impact of AI across industries and the company's commitment to integrating AI with traditional Chinese medicine to standardize and visualize health management [5][7] - AnDun's participation in the conference highlights China's advancements in AI healthcare and supports the "Healthy China" initiative, indicating a growing trend of AI in health management [7]